← Back to patent-cliff list
CAS 625852-10-0
3-[1(R)-Hydroxyethyl]phenol
Codes: (II)145089-11-a
Application context (from source-drug indications)
Alzheimer's diseaseRivastigmine TartrateDementiaRivastigmine TartrateParkinson's diseaseRivastigmine Tartrate抗胆碱能综合征Rivastigmine Tartrate神经行为学表现Rivastigmine TartrateCognitive impairmentRivastigmine Tartrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Rivastigmine Tartrate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(3-Hydroxyphenyl)ethanone→3-[1(R)-Hydroxyethyl]phenol→3-[(1R)-1-[(Methanesulfonyl)oxy]ethyl]phenyl methanesulfonate→Dimethylamine anhydrous→3-[(1S)-1-(Dimethylamino)ethyl]phenyl methanesulfonate→(-)-3-((1S)-1-(Dimethylamino)ethyl)phenol→N-Ethyl-N-methylcarbamic chloride→(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate→3-Acetylphenyl ethyl(methyl)carbamate→3-[(1R)-1-Hydroxyethyl]phenyl ethyl(methyl)carbamate→(1R)-1-(3-[[Ethyl(methyl)carbamoyl]oxy]phenyl)ethyl methanesulfonate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.